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We report that the clinically used antitumor drug mitomycin C is reductively activated in vitro by simple thiols; a mechanism for this 




Mitomycin C (MC, 1)
1
 is a natural antitumour antibiotic used in anticancer therapy
2
 that requires reductive activation to exert its 
biological activity.
3
 After bioreduction, MC generates a bifunctional electrophile (4, scheme 1) that alkylates cellular nucleophiles, in 
particular the complementary strands of DNA.
 4
 A number of enzymes are known to activate MC in mammalian cells.
5
 Recent reports 
indicate that proteins containing a dithiol active site are implicated in the cellular activation of MC.
6
 Incongruently, MC was reported to 
be inert to reductive activation by monothiols (glutathione) and dithiols (DTT),
7,8
 We decided to re-examine the reaction of MC with 
thiols, in particular after recent reports linked the thioredoxin-like domains of GRP58 to the activation of MC in cancer cells, an explicit 
sign of the involvement of the dithiol group in the cellular activation of MC. The results we present here reconcile this apparent 
paradox.  
 
Figure 1. Structure of mitomycin C and mitomycin A. 
Results and discussion 
The UV analysis of a reaction containing MC and a large excess of DTT (0.1 M) at neutral pH clearly showed the gradual formation of 
mitosene compounds (6, Scheme 1) at the expense of MC (figure 2), the reaction reaching completion in about 120 minutes, as judged 
by a constant UV spectra. When MC was treated with mercaptoethanol in similar conditions only a marginal conversion of MC to 




A kinetic analysis of the reaction was then performed. The rate of disappearance of MC by treatment with DTT was measured by the 
decline of the UV absorbance at 360 nm (figure 3). The decay of MC displayed the shape of a sigmoidal curve, characteristic of an 





Figure 2. UV assay of the reduction of mitomycin C by DTT. Reaction times are indicated on top of each spectrum. 




 reductions. This mechanism is 
based on the large redox potential difference between the mitosane (1) and mitosene (4) structures (scheme 1). Thus, the 
leucomitosene species, e.g. 5 and 6, transfer their electron(s) to unreduced MC, creating an electron transfer chain reaction, provided 




Figure 3. (a) Dependence on the concentration of DTT. All reactions contain 30 µM. MC at pH 9.0. Concentrations of DTT were as indicated in the chart. 
(b) Relationship between t1/2-1 and DTT concentration at pH 9.0.; [MC] = 5  
The identity of the mitosenes formed in the reaction of MC with DTT was studied by LCMS. MC was activated with substoichometric 
DTT at pH 9.5 until all MC is consumed, then quenched with diluted aqueous buffer at neutral pH. LCMS analysis showed the formation 















































The kinetics of activation of MC were analyzed in detail, varying the thiol (DTT, 1,3-propanedithiol, dihydrolipoic acid and 
mercaptoethanol), the concentration of thiol, the concentration of MC and the pH. The rate of reaction (plotted as t1/2
-1
) was linearly 
proportional to the concentration of both thiol and MC, concordantly with the proposed mechanism.  
Based on these findings we propose that the activation of MC by thiols occurs by a mechanism analogous to the one we previously 
proposed for the activation of MA by thiols:
9a
 an initial conjugate addition of thiolate to the quinone of MC, followed by an internal 
redox reaction to give the hydroquinone of MC and the corresponding disulfide (scheme 2). 
 
Scheme 2. Hypothesis for the mechanism of activation of MC by thiols.  
 
 
Figure 4. (a) pH dependence of the rates of reaction of MC with the three thiols evaluated in this work: DTT (red); 1,3-propanedithiol (blue); MER (green); 




)max, where t1/2, is the time required for 50% conversion of MC at a given pH 
determined from the curves of decay of MC, and ( t1/2
-1
)max is the maximum rate observed at the pH values assayed for each thiol. (b) Theoretical pH 
dependence derived from equation 1 for the dithols used in this work; color codes are the same as in figure 5a. 
When the pH dependence was studied, it was found that the reaction rate follows initially a linear relationship until a certain pH, 
reaches a maximum value and then decreases. The optimum pH values for the activation of MC with the three thiols used in this work 
were all around the sulphydriyl pKa value of each thiol (figure 4). The graphic data of pH-dependence (figure 4) clearly illustrates the 
reason why earlier attempts to activate MC at pH around neutral failed: extrapolation of the linear data points (below the optimum pH) 
indicates that as the pH of the reaction approaches 8 (for mercaptoethanol and propanedithiol) or 7 (for DTT), the half-time for the 
conversion of MC tends to be infinite, particularly with the relatively low concentrations of thiols that were employed in the earlier 
assays.
6,9b
 The pH dependence data concords with a mechanism analogous to the one we previously proposed for the reduction of MA 
by dithiols. The formation of the intermediate requires a thiolate anion, while its conversion to hydroquinone requires a protonated 
thiol (scheme 3). The fact that reductions of MC by dithiols are favored at a pH bounded by the pKa1 and pKa2 of the dithiol lends 
support to the proposed mechanism, as it is precisely at those pH values where higher concentrations of both thiol and thiolate will be 
present. Additionally, the observed pH dependence could be fitted to equation I where the rate of reaction is dependent on the pH and 
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Equation 1 . k is the relative rate of activation of MC; kmax is the maximum rate; Ka1 and Ka2 are the equilibrium constants for deprotonation of the thiol 
groups in the dithiol. The pKa values shown in figure 5 were used, except for DHLA, where a pKa2 of 11.5 was used, as only an average value of pKa for 
DHLA is reported in the literature (22). 
 
 
Are the results presented here relevant in vivo? In principle, it would appear not to be so, as the pH required for an efficient 
reaction is distant from regular physiological values. We consider improbable the involvement of glutathione (a cellular monothiol) in 
the activation of MC in vivo, as the concentrations of thiolate required for activation are several orders of magnitude higher than those 
present in cells. Likewise, free lipoate coenzymes are unlikely to contribute significantly to the cellular activation of MC, as the optimum 
pH for the activation with DHLA is 4 units above physiological pH values. However, the rationale changes if we consider the exceptional 
acid-base properties of other biological dithiols. Proteins of the thioredoxin superfamily (thioredoxin, glutaredoxin, protein disulphide-
isomerases, disulfide bond formation protein A) contain a dithiol in the active site, where the pKa of the N-terminal cysteines in the -
Cys-X-X-Cys- motif is abnormally lo
12
 while thioredoxin reductases contain an even more acidic selenol group. At physiological pH, both 




In the mechanism we postulate (scheme 3), the optimum pH for the activation of MC by dithiols is predicted to present a value 
flanked by the pKa values of their sulfhydryl residues. At such pH values, the most acidic thiol (or selenol) group will be deprotonated, 
and the nucleophilic addition (first step in scheme 3) will be favored. The second sulfhydryl group of the dithiol presents pKa values 
above 8 both for Trx and TrxR, and will be mostly protonated at neutral or acidic pH (figure 5), therefore favoring the second step in the 
proposed mechanism (scheme 3). As a result, our mechanistic model predicts that the Trx (pKa1 = 7.1) might activate MC at pH around 
neutral, and TrxR (pKa1 = 5.8) could be capable of activating MC even at acidic pH values. The fact that reductions of MC by dithiols are 
favoured at pH values bounded by the pKa1 and pKa2 of the dithiol also concords with the proposed mechanism. The menchanism 
involves thiol groups in both the protonated and deprotonated states, and it is precisely at those pH values where the rates should be 
maximized, since higher concentrations of both species must be present.  
Conclusion 
We conclude that the activation of MC with DTT can possibly be reproduced in living organisms by biological thiols.
14
 The results 
presented here serve and a chemical foundation to explain the reported involvement of biological dithiols in the modulation of 
mitomycin C cytotoxicity: dithiols could detoxify MC by activating MC in the cytosol, where it would be hydrolized to inactive 
metabolites, and could activate MC to form toxic metabolites by reducing MC in close proximity to the biological target. Additional 
research is currently being performed be determine if Trx and other dithiol-containing proteins are indeed capable of reducing MC. 
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